These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9562689)

  • 1. Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse.
    Eyles JE; Sharp GJ; Williamson ED; Spiers ID; Alpar HO
    Vaccine; 1998 Apr; 16(7):698-707. PubMed ID: 9562689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines.
    Eyles JE; Spiers ID; Williamson ED; Alpar HO
    Vaccine; 1998 Dec; 16(20):2000-9. PubMed ID: 9796057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits.
    Eyles JE; Williamson ED; Spiers ID; Stagg AJ; Jones SM; Alpar HO
    J Control Release; 2000 Jan; 63(1-2):191-200. PubMed ID: 10640592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague.
    Yamanaka H; Hoyt T; Yang X; Golden S; Bosio CM; Crist K; Becker T; Maddaloni M; Pascual DW
    Infect Immun; 2008 Oct; 76(10):4564-73. PubMed ID: 18694965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
    Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ
    Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated immune response and Th/Th cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis.
    Gupta G; Khan AA; Rao DN
    Scand J Immunol; 2010 Mar; 71(3):186-98. PubMed ID: 20415784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against plague following immunisation with microencapsulated V antigen is reduced by co-encapsulation with IFN-gamma or IL-4, but not IL-6.
    Griffin KF; Eyles JE; Spiers ID; Alpar HO; Williamson ED
    Vaccine; 2002 Nov; 20(31-32):3650-7. PubMed ID: 12399192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection studies following bronchopulmonary and intramuscular immunisation with yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacy.
    Eyles JE; Williamson ED; Spiers ID; Alpar HO
    Vaccine; 2000 Aug; 18(28):3266-71. PubMed ID: 10869771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
    Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
    PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice.
    Uppada SB; Bhat AA; Sah A; Donthamshetty RN
    Vaccine; 2011 Nov; 29(50):9352-60. PubMed ID: 22001881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose intranasal subunit vaccine rapidly clears secondary sepsis in a high-dose pneumonic plague infection.
    D'Arco C; McCormick AA; Arnaboldi PM
    Vaccine; 2021 Mar; 39(9):1435-1444. PubMed ID: 33531196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Yersinia pestis F1 antigen-loaded microspheres vaccine against plague.
    Huang SS; Li IH; Hong PD; Yeh MK
    Int J Nanomedicine; 2014; 9():813-22. PubMed ID: 24550673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague.
    Wagner DA; Kelly SM; Petersen AC; Peroutka-Bigus N; Darling RJ; Bellaire BH; Wannemuehler MJ; Narasimhan B
    Acta Biomater; 2019 Dec; 100():326-337. PubMed ID: 31610342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single dose sub-unit vaccine protects against pneumonic plague.
    Williamson ED; Eley SM; Stagg AJ; Green M; Russell P; Titball RW
    Vaccine; 2000 Oct; 19(4-5):566-71. PubMed ID: 11027822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model.
    Williamson ED; Vesey PM; Gillhespy KJ; Eley SM; Green M; Titball RW
    Clin Exp Immunol; 1999 Apr; 116(1):107-14. PubMed ID: 10209513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yersinia pestis YadC: a novel vaccine candidate against plague.
    Murphy BS; Wulff CR; Garvy BA; Straley SC
    Adv Exp Med Biol; 2007; 603():400-14. PubMed ID: 17966436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague.
    Williamson ED; Eley SM; Stagg AJ; Green M; Russell P; Titball RW
    Vaccine; 1997 Jul; 15(10):1079-84. PubMed ID: 9269050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
    Sabhnani L; Manocha M; Sridevi K; Shashikiran D; Rayanade R; Rao DN
    FEMS Immunol Med Microbiol; 2003 Oct; 38(3):215-29. PubMed ID: 14522457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local and systemic immune response to a microencapsulated sub-unit vaccine for plague.
    Williamson ED; Sharp GJ; Eley SM; Vesey PM; Pepper TC; Titball RW; Alpar HO
    Vaccine; 1996 Dec; 14(17-18):1613-9. PubMed ID: 9032889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.